Position in MRK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,291,168
+$25,958 QoQ
Shares Held
10,048
-4.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,915
of 3,769 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITHBRIDGE ASSET MANAGEMENT INC/DE holds $39,618,201 across 7 Drug Manufacturers - General names. MRK ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,597 | $11,072,330 | |
| 2 | NVS |
Novartis AG
|
49,133 | $7,700,123 | |
| 3 | ABBV |
AbbVie Inc.
|
29,215 | $7,351,662 | |
| 4 | LLY |
ELI LILLY & Co
|
5,883 | $7,056,247 | |
| 5 | NVO |
Novo Nordisk A S
|
102,069 | $4,893,187 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
10,048 | $1,291,168 | |
| 7 | AMGN |
Amgen Inc
|
700 | $253,484 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,291,168 | 10,048 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,265,210 | 10,518 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $854,079 | 8,114 | Shares | Sole | 2026-02-11 | |
| 2025-03-31 | $223,412 | 2,489 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $301,501 | 2,655 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $347,259 | 2,805 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $348,216 | 2,639 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $287,703 | 2,639 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $283,524 | 2,754 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $288,936 | 2,504 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $254,165 | 2,389 | Shares | Sole | 2023-04-20 | |
| No filing history on record for this holder in this stock. | ||||||